From Medscape Neurology

Coverage from the

38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2022

October 26 - 28, 2022; Amsterdam, The Netherlands

October 26 - 28, 2022 Amsterdam, The Netherlands
  • ECTRIMS 2022 Can MS Be Stopped Early in its Tracks? The first randomized trial of a disease-modifying therapy in radiological isolated syndrome, the earliest pre-clinical phase of MS, suggests dimethyl fumarate reduced the risk of a first clinical event by 80%.
  • ECTRIMS 2022 Stem Cell Transplant Trumps Fingolimod for RRMS Relapse Risk Autologous hematopoietic stem cell transplantation is linked to significantly lower relapse rates than fingolimod in patients with relapsing-remitting multiple sclerosis. But adverse events are common.

Conference News

Popular News from ECTRIMS 2021

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives